Published in Br J Dermatol on May 01, 2006
Effects of bosentan on the skin lesions: an observational study from a single center in Japan. Rheumatol Int (2008) 0.87
Functional autoantibodies in systemic sclerosis. Semin Immunopathol (2015) 0.76
Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis. Int J Rheumatol (2011) 0.75
A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO J (1995) 2.34
Internal jugular vein thrombosis: outcome and risk factors. QJM (2010) 2.24
Clearance of HIV infection in 12 perinatally infected children: clinical, virological and immunological data. AIDS (1995) 1.80
Tongue involvement revealing sarcoidosis. QJM (2008) 1.68
Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum (2002) 1.67
p56lck interacts via its src homology 2 domain with the ZAP-70 kinase. J Exp Med (1994) 1.60
An uncommon association: celiac disease and dermatomyositis in adults. Clin Exp Rheumatol (2001) 1.49
Peripheral arterial disease and isolated systolic hypertension: the ATTEST study. J Hum Hypertens (2008) 1.49
Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy. Aliment Pharmacol Ther (2006) 1.46
Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol (2001) 1.46
Gangrene of the perineum. Urology (1996) 1.43
[The French translation and cultural adaptation of the SRI questionnaire. A questionnaire to assess health-related quality of life in patients with chronic respiratory failure and domiciliary ventilation]. Rev Mal Respir (2012) 1.42
[COPD and inflammation: statement from a French expert group: inflammation and remodelling mechanisms]. Rev Mal Respir (2010) 1.40
[Hypoxemic respiratory failure: non-invasive ventilation protects fragile patients]. Rev Mal Respir (2003) 1.39
[Usefulness of magnetic resonance imaging in Churg-Strauss syndrome related cardiac involvement. A case series of three patients and literature review]. Rev Med Interne (2010) 1.38
[Acute respiratory failure due to Mycoplasma pneumonia]. Rev Mal Respir (2013) 1.38
Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore) (1999) 1.26
Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature. Br J Dermatol (2006) 1.10
The nucleotide sequence of Saccharomyces cerevisiae chromosome XIV and its evolutionary implications. Nature (1997) 1.09
[Partial monosomy of the short arm of chromosome 10, associated with Rieger's syndrome and a Di George type partial immunodeficiency]. Ann Pediatr (Paris) (1984) 1.08
Nephrobronchial fistula secondary to xantogranulomatous pyelonephritis. Ann Thorac Surg (1999) 1.07
Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody. Br J Dermatol (2009) 1.07
A new vaginal procedure for cystocele repair and treatment of stress urinary incontinence. J Urol (1996) 1.06
Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis. Br J Dermatol (2007) 1.01
Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev (2013) 1.00
Estrogen-induced growth inhibition of human seminoma cells expressing estrogen receptor beta and aromatase. J Mol Endocrinol (2005) 0.97
Disrupted traffic of connexin 43 in human testicular seminoma cells: overexpression of Cx43 induces membrane location and cell proliferation decrease. J Pathol (2004) 0.96
Distinct inflammatory signals have physiologically divergent effects on epigenetic regulation of Foxp3 expression and Treg function. Am J Transplant (2011) 0.95
Gastrointestinal complications: the most frequent internal complications of systemic sclerosis. Rheumatology (Oxford) (2009) 0.95
Fabry disease 'The New Great Imposter': results of the French Observatoire in Internal Medicine Departments (FIMeD). Clin Genet (2011) 0.95
Polymyositis, cranial neuropathy, autoimmune hepatitis, and hepatitis C. Ann Rheum Dis (2000) 0.95
Acute adrenal failure secondary to bilateral infarction of the adrenal glands as the first manifestation of primary antiphospholipid antibody syndrome. Ann Rheum Dis (1997) 0.94
Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum (2001) 0.94
Ultrastructural localization of interferon-inducible double-stranded RNA-activated enzymes in human cells. Exp Cell Res (1998) 0.93
Mapping of seminal plasma proteins by two-dimensional gel electrophoresis in men with normal and impaired spermatogenesis. Mol Hum Reprod (2001) 0.93
[Influence of protein S deficiency on the arterial thrombosis risk]. Presse Med (1991) 0.92
Churg-Strauss syndrome associated with montelukast therapy. QJM (2008) 0.91
Gastrointestinal mucosal abnormalities using videocapsule endoscopy in systemic sclerosis. Aliment Pharmacol Ther (2014) 0.91
Neutrophilic myositis as an extracutaneous manifestation of neutrophilic dermatosis. J Am Acad Dermatol (2001) 0.90
Cloning of murine SeGpx cDNA and synthesis of mutated GPx proteins in Escherichia coli. Gene (1991) 0.90
Löfgren's syndrome as the first manifestation of acute infection due to Chlamydia pneumoniae: a prospective study. Clin Infect Dis (1999) 0.90
Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome. Respir Med (2012) 0.90
Watermelon stomach in systemic sclerosis: its incidence and management. Aliment Pharmacol Ther (2008) 0.90
The hormonal flare-up following gonadotrophin-releasing hormone agonist administration is influenced by a progestogen pretreatment. Hum Reprod (1996) 0.89
Drug-binding properties of rat alpha 1-foetoprotein. Binding of warfarin, phenylbutazone, azapropazone, diazepam, digitoxin and cholic acid. Biochem J (1984) 0.89
An uncommon association: Sjögren's syndrome and autoimmune myelofibrosis. Rheumatology (Oxford) (1999) 0.89
Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis. J Rheumatol (1999) 0.88
[Acute reactive arthritis after intravesical instillation of bacillus Calmette-Guérin. Two case reports and literature review]. Rev Med Interne (2010) 0.88
Anti-Müllerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia. Hum Reprod (1999) 0.88
Typhlitis as a complication of alemtuzumab therapy. Haematologica (2007) 0.88
Increased hyaluronan and hyaluronidase production and hyaluronan degradation in injured aorta of insulin-resistant rats. Arterioscler Thromb Vasc Biol (2000) 0.88
Determinants of severity for superficial cellutitis (erysipelas) of the leg: a retrospective study. Eur J Intern Med (2004) 0.88
A weekly schedule of docetaxel for metastatic hormone-refractory prostate cancer. Oncology (2004) 0.86
Mesenteric venous thrombosis revealing both factor II G20212A mutation and hyperhomocysteinemia related to pernicious anemia. Gastroenterology (2000) 0.86
[Consequences of atmospheric pollution fluctuations in patients with COPD]. Rev Mal Respir (2010) 0.86
Diamond-blackfan anemia and growth status: the French registry. J Pediatr (2005) 0.86
Study of the expression of the genetic variants of human alpha1-acid glycoprotein in healthy subjects using isoelectric focusing and immunoblotting. J Chromatogr B Biomed Sci Appl (1998) 0.85
[Infectious aortic aneurysms. A case series of 10 patients]. Rev Med Interne (2010) 0.85
A low molecular weight heparin decreases plasma aldosterone in patients with primary hyperaldosteronism. Eur J Clin Pharmacol (1992) 0.84
Gastric involvement in systemic sclerosis: a prospective study. Am J Gastroenterol (2001) 0.84
Effects of short-term GnRH agonist--human menopausal gonadotrophin stimulation in patients pre-treated with progestogen. Hum Reprod (1992) 0.84
Intravenous immunoglobulin for treatment of gastro-intestinal haemorrhage in dermatomyositis. Ann Rheum Dis (2001) 0.84
[Hypoglycemia induced by cibenzoline in the elderly]. Rev Med Interne (1991) 0.84
Differences in the binding of thyroid hormones and indoles by rat alpha 1-fetoprotein and serum albumin. Eur J Biochem (1982) 0.83
Sequential step-up and step-down dose regimen: an alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome. Hum Reprod (1996) 0.83
Clinical approach to inherited metabolic diseases in the neonatal period: a 20-year survey. J Inherit Metab Dis (1989) 0.83
Beyond corticosteroids: future prospects in the management of inflammation in COPD. Eur Respir Rev (2011) 0.83
Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab. Rheumatology (Oxford) (2005) 0.83
Autoimmune hepatitis and systemic sclerosis: a new overlap syndrome? Rheumatology (Oxford) (2001) 0.82
Intravenous immunoglobulins as treatment of severe cutaneous polyarteritis nodosa. Intern Med J (2012) 0.82
Risk factors of vitamin K antagonist overcoagulation. QJM (2011) 0.82
A case of giant chondrosarcoma of the cricoid cartilage presenting as a superior mediastinal tumour. Eur J Cardiothorac Surg (1998) 0.82
Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients. Angiology (1997) 0.81
Multidimensional analysis of clinical symptoms in patients with Fabry's disease. Int J Clin Pract (2013) 0.81
Incidence and prognosis of cancer associated with bilateral venous thrombosis: a prospective study of 103 patients. J Thromb Haemost (2004) 0.81
[Muscle lymphoma: a case report]. Rev Med Interne (2008) 0.81
[Langerhans histiocytosis in adults: cutaneous and mucous lesion regression after treatment with thalidomide]. Rev Med Interne (1998) 0.81
Evidence for an intrinsic factor bound to rat alpha 1 fetoprotein. Fluorescence investigation. Reprod Nutr Dev (1981) 0.81
Drug-binding properties of rat alpha-foetoprotein. Specificities of the phenylbutazone-binding and warfarin-binding sites. Biochem J (1986) 0.81
[Cardiopulmonary function before and after cyclophosphamide treatment in severe systemic sclerosis: comparison of monthly intravenous bolus and autologous haematopoietic stem cell transplantation]. Rev Med Interne (2005) 0.81
Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study. Arthritis Rheum (1998) 0.81
The vitamin status of low birth weight infants and their mothers. J Pediatr Gastroenterol Nutr (1984) 0.80
Follow-up of muscular sarcoidosis using fluorodeoxyglucose positron emission tomography. QJM (2010) 0.80
Intravenous immunoglobulins and octreotide as treatment of intestinal pseudo-obstruction revealing a recurrence of polymyositis. Rheumatology (Oxford) (2001) 0.80